FDA Inspection
Peter Charles Klatsky, M.D., Inc.Peter Charles Klatsky, M.D., Inc. – FDA Inspection, Sep 23, 2025
Record Details
This FDA Inspection record concerns Peter Charles Klatsky, M.D., Inc., with an inspection on September 23, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · f7e15600-aaf7-462e-955a-92930655e850
Inspection Facts
- Inspection number
- 1284460
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.47(b)Review and approval of procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Peter Charles Klatsky, M.D., Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Peter Charles Klatsky, M.D., Inc.
- FDA Inspection 1166059 - 2022-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.